Analysis of a food-borne fungal pathogen outbreak: Virulence and genome of a Mucor circinelloides isolate from yogurt

mBio

Volumn 5, Issue 4, 2014, Pages

  Lee, Soo Chan ^a   Blake Billmyre, R ^a   Li, Alicia ^a   Carson, Sandra ^b   Sykes, Sean M ^c   Huh, Eun Young ^d   Mieczkowski, Piotr ^d   Ko, Dennis C ^a   Cuomo, Christina A ^c   Heitman, Joseph ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Dental Department Corpus Christi State Supported Living Center ^*  (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

YOGHURT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIARRHEA; DISEASE ASSOCIATION; FECES ANALYSIS; FOOD CONTAMINATION; FOOD POISONING; FUNGAL GENETICS; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS ISOLATION; GASTROINTESTINAL TRACT; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; IMMUNOCOMPETENT CELL; MALE; MOUSE; MUCOR CIRCINELLOIDES; NAUSEA; NONHUMAN; NUCLEOTIDE SEQUENCE; VOMITING; ZYGOSPORE; ANIMAL; BAGG ALBINO MOUSE; EPIDEMIC; FUNGAL GENOME; GENETICS; MICROBIOLOGY; MUCOR; MUCORMYCOSIS; PATHOGENICITY; VIRULENCE;

MUCOR CIRCINELLOIDES;

ANIMALS; DISEASE OUTBREAKS; GENOME, FUNGAL; HUMANS; MALE; MICE; MICE, INBRED BALB C; MUCOR; MUCORMYCOSIS; VIRULENCE; YOGURT;

EID: 84908279911     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01390-14     Document Type: Article

References (53)

1. Newell DG, Koopmans M, Verhoef L, Duizer E, Aidara-Kane A, Sprong H, Opsteegh M, Langelaar M, Threfall J, Scheutz F, van der Giessen J, Kruse H. 2010. Food-borne diseases—the challenges of 20 years ago still persist while new ones continue to emerge. Int. J. Food Microbiol. 139(Suppl1):S3-S15. http://dx.doi.org/10.1016/j.ijfoodmicro.2010.01.021.
2. Denny J, McLauchlin J. 2008. Human Listeria monocytogenes infections in Europe—an opportunity for improved European surveillance. Euro Surveill. 13(13):8082. http://www.eurosurveillance.org/ViewArticle.aspx ?ArticleId_8082.
3. Koopmans M, Vennema H, Heersma H, van Strien E, van Duynhoven Y, Brown D, Reacher M, Lopman B, European Consortiumon Foodborne Viruses. 2003. Early identification of common-source foodborne virus outbreaks in Europe. Emerg. Infect. Dis. 9:1136-1142. http://dx.doi.org/10.3201/eid0909.020766.
4. Lopman B, Vennema H, Kohli E, Pothier P, Sanchez A, Negredo A, Buesa J, Schreier E, Reacher M, Brown D, Gray J, Iturriza M, Gallimore C, Bottiger B, Hedlund KO, Torvén M, von Bonsdorff CH, Maunula L, Poljsak-Prijatelj M, Zimsek J, Reuter G, Szücs G, Melegh B, Svennson L, van Duijnhoven Y, Koopmans M. 2004. Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet 363:682-688. http://dx.doi.org/10.1016/S0140-6736(04)15641-9.
5. Kroneman A, Verhoef L, Harris J, Vennema H, Duizer E, van Duynhoven Y, Gray J, Iturriza M, Böttiger B, Falkenhorst G, Johnsen C, von Bonsdorff C-H, Maunula L, Kuusi M, Pothier P, Gallay A, Schreier E, Höhne M, Koch J, Szücs G, Reuter G, Krisztalovics K, Lynch M, McKeown P, Foley B, Coughlan S, Ruggeri FM, Bartolo I, Vainio K, Isakbaeva E, Poljsak-Prijatelj M, Grom AH, Mijovski JZ, Bosch A, Buesa J, Fauquier AS, Hernandéz-Pezzi G, Hedlund K-O, Koopmans M. 2008. Analysis of integrated virological and epidemiological reports of norovirus outbreaks collected within the Foodborne Viruses in Europe Network from 1 July 2001 to 30 June 2006. J. Clin. Microbiol. 46: 2959-2965. http://dx.doi.org/10.1128/JCM.00499-08.
6. Siebenga J, Kroneman A, Vennema H, Duizer E, Koopmans M, Food-Borne Viruses in Europe Network. 2008. Food-Borne Viruses in Europe Network report: the norovirus GII.4 2006b (for US named Minerva-like, for Japan Kobe034-like, for UK V6) variant now dominant in early seasonal surveillance. Euro Surveill. 10(2):8009. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId_8009.
7. FDA. 5 September 2013. Chobani, Inc. Voluntarily Recalls Greek Yogurt Because of Product Concerns. Press release. U.S. FDA, Washington, DC. http://www.fda.gov/safety/recalls/ucm367298.htm.
8. Today, USA. 10 September 2013. FDA receives dozens of reports of illness from yogurt USA Today, McLean, VA http://www.usatoday.com/story/news/nation/2013/09/10/fda-illness-yogurt/2792291/.
9. Chayakulkeeree M, Ghannoum MA, Perfect JR. 2006. Zygomycosis: the re-emerging fungal infection. Eur. J. Clin. Microbiol. Infect. Dis. 25: 215-229. http://dx.doi.org/10.1007/s10096-006-0107-1.
10. Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. 2012. Pathogenesis of mucormycosis. Clin. Infect. Dis. 54:S16-S22. http://dx.doi.org/10.1093/cid/cir865.
11. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ. 2005. Epidemiology and outcome of Zygomycosis: a review of 929 reported cases. Clin. Infect. Dis. 41:634-653. http://dx.doi.org/10.1086/432579.
12. Dromer F, McGinnis MR. 2003. Zygomycosis, p. 297-308. In Annaissie EJ, McGinnis MR, Pfaller MA (ed), Clinical mycology. Churchill Livingstone, New York, NY.
13. Ibrahim AS, Spellberg B. 2006. Zygomycetes as agents of infectious disease in humans, p 429-440. In Heitman J, Filler SG, Edwards JE, Jr, Mitchell AP (ed), Molecular principles of fungal pathogenesis. ASM Press, Washington, DC.
14. Spellberg B. 2012. Gastrointestinal mucormycosis: an evolving disease. Gastroenterol. Hepatol. 8:140-142.
15. Aboltins CA, Pratt WA, Solano TR. 2006. Fungemia secondary to gastrointestinal Mucor indicus infection. Clin. Infect. Dis. 42:154-155. http://dx.doi.org/10.1086/498751.
16. Oliver MR, Van Voorhis WC, Boeckh M, Mattson D, Bowden RA. 1996. Hepatic mucormycosis in a bone marrow transplant recipient who ingested naturopathic medicine. Clin. Infect. Dis. 22:521-524. http://dx.doi.org/10.1093/clinids/22.3.521.
17. Singh N, Gayowski T, Singh J, Yu VL. 1995. Invasive gastrointestinal zygomycosis in a liver transplant recipient: case report and review of zygomycosis in solid-organ transplant recipients. Clin. Infect. Dis. 20: 617-620. http://dx.doi.org/10.1093/clinids/20.3.617.
18. Thomson SR, Bade PG, Taams M, Chrystal V. 1991. Gastrointestinal mucormycosis. Br. J. Surg. 78:952-954. http://dx.doi.org/10.1002/bjs.1800780819.
19. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. 2012. Epidemiology and clinical manifestations of mucormycosis. Clin. Infect. Dis. 54:S23-S34. http://dx.doi.org/10.1093/cid/cir866.
20. Singh N, Aguado JM, Bonatti H, Forrest G, Gupta KL, Safdar N, John GT, Pursell KJ, Muñoz P, Patel R, Fortun J, Martin-Davila P, Philippe B, Philit F, Tabah A, Terzi N, Chatelet VR, Kusne S, Clark N, Blumberg E, Julia MB, Humar A, Houston S, Lass-Flörl C, Johnson L, Dubberke ER, Barron MA, Lortholary O. 2009. Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J. Infect. Dis. 200:1002-1011. http://dx.doi.org/10.1086/605445.
21. Li CH, Cervantes M, Springer DJ, Boekhout T, Ruiz-Vazquez RM, Torres-Martinez SR, Heitman J, Lee SC. 2011. Sporangiospore size dimorphism is linked to virulence of Mucor circinelloides. PLoS Pathog. 7:e1002086. http://dx.doi.org/10.1371/journal.ppat.1002086.
22. Schipper MAA. 1976. On Mucor circinelloides, Mucor racemosus, and related species. Stud. Mycol. 12:1-40.
23. FDA. 18 September 2013. FDA establishment inspection report, Chobani Idaho. FEI 3009726115. U.S. FDA, Washington, DC. http://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofGlobalRegulatoryOperationsandPolicy/ORA/ORAElectronicReadingRoom/UCM376634.pdf
24. James TY, Kauff F, Schoch CL, Matheny PB, Hofstetter V, Cox CJ, Celio G, Gueidan C, Fraker E, Miadlikowska J, Lumbsch HT, Rauhut A, Reeb V, Arnold AE, Amtoft A, Stajich JE, Hosaka K, Sung GH, Johnson D, O’Rourke B, Crockett M, Binder M, Curtis JM, Slot JC, Wang Z, Wilson AW, Schüssler A, Longcore JE, O’Donnell K, Mozley-Standridge S, Porter D, Letcher PM, Powell MJ, Taylor JW, White MM, Griffith GW, Davies DR, Humber RA, Morton JB, Sugiyama J, Rossman AY, Rogers JD, Pfister DH, Hewitt D, Hansen K, Hambleton S, Shoemaker RA, Kohlmeyer J, Volkmann-Kohlmeyer B, et al. 2006. Reconstructing the early evolution of fungi using a six-gene phylogeny. Nature 443:818-822. http://dx.doi.org/10.1038/nature05110.
25. Beopoulos A, Cescut J, Haddouche R, Uribelarrea JL, Molina-Jouve C, Nicaud JM. 2009. Yarrowia lipolytica as a model for bio-oil production. Prog. Lipid Res. 48:375-387. http://dx.doi.org/10.1016/j.plipres.2009.08.005.
26. Papanikolaou S, Aggelis G. 2010. Yarrowia lipolytica: a model microorganism used for the production of tailor-made lipids. Eur. J. Lipid Sci. Technol. 112:639-654. http://dx.doi.org/10.1002/ejlt.200900197.
27. Findley K, Oh J, Yang J, Conlan S, Deming C, Meyer JA, Schoenfeld D, Nomicos E, Park M, Kong HH, Segre JA, Segre JA. 2013. Topographic diversity of fungal and bacterial communities in human skin. Nature 498: 367-370. http://dx.doi.org/10.1038/nature12171.
28. Lee SC, Corradi N, Byrnes EJ, Torres-Martinez S, Dietrich FS, Keeling PJ, Heitman J. 2008. Microsporidia evolved from ancestral sexual fungi. Curr. Biol. 18:1675-1679. http://dx.doi.org/10.1016/j.cub.2008.09.030.
29. Chiller TM, Roy M, Nguyen D, Guh A, Malani AN, Latham R, Peglow S, Kerkering T, Kaufman D, McFadden J, Collins J, Kainer M, Duwve J, Trump D, Blackmore C, Tan C, Cleveland AA, MacCannell T, Muehlenbachs A, Zaki SR, Brandt ME, Jernigan JA, Multistate Fungal Infection Clinical Investigation Team.2013. Clinical findings for fungal infections caused by methylprednisolone injections. N. Engl. J. Med. 369: 1610-1619. http://dx.doi.org/10.1056/NEJMoa1304879.
30. Keller NP, Turner G, Bennett JW. 2005. Fungal secondary metabolism— from biochemistry to genomics. Nat. Rev. Microbiol. 3:937-947. http://dx.doi.org/10.1038/nrmicro1286.
31. Panaccione DG. 2005. Origins and significance of ergot alkaloid diversity in fungi. FEMS Microbiol. Lett. 251:9-17. http://dx.doi.org/10.1016/j.femsle.2005.07.039.
32. Caporael LR. 1976. Ergotism: the Satan loosed in Salem? Science 192: 21-26. http://dx.doi.org/10.1126/science.769159.
33. Flotte TJ, Bell DA. 1989. Role of skin lesions in the Salem witchcraft trials. Am. J. Dermatopathol. 11:582-587. http://dx.doi.org/10.1097/00000372-198912000-00014.
34. Wannop CC. 1961. The histopathology of turkey “X” disease in Great Britain. Avian Dis. 5:371-381. http://dx.doi.org/10.2307/1587768.
35. Amaike S, Keller NP. 2011. Aspergillus flavus. Annu. Rev. Phytopathol. 49:107-133. http://dx.doi.org/10.1146/annurev-phyto-072910-095221.
36. Joff AZ. 1978. Fusarium poae and F. sporotrichioides as principal causal agents of alimentary toxic aleukia, p 21-86. In Wyllie TD, Morehouse LG (ed), Mycotoxic fungi, mycotoxins, mycotoxicoses: an encyclopedic handbook, vol 3. Marcel Dekker, New York, NY.
37. Partida-Martinez LP, Hertweck C. 2005. Pathogenic fungus harbours endosymbiotic bacteria for toxin production. Nature 437:884-888. http://dx.doi.org/10.1038/nature03997.
38. Kleinfeld K, Jones P, Riebau D, Beck A, Paueksakon P, Abel T, Claassen DO. 2013. Vascular complications of fungal meningitis attributed to in-jections of contaminated methylprednisolone acetate. JAMA Neurol. 70: 1173-1176. http://dx.doi.org/10.1001/jamaneurol.2013.3586.
39. Kuehn BM. 2013. CDC probes new outbreak associated with compounded steroids. JAMA 309:2541. http://dx.doi.org/10.1001/jama.2013.7329.
40. Smith RM, Tipple M, Chaudry MN, Schaefer MK, Park BJ. 2013. Relapse of fungal meningitis associated with contaminated methylprednisolone. N. Engl. J. Med. 368:2535-2536. http://dx.doi.org/10.1056/NEJMc1306560.
41. Bullock JD. 2008. An outbreak of Fusarium keratitis associated with contact lens use in the northeastern United States. Cornea 27:973-974. http://dx.doi.org/10.1097/ICO.0b013e318177011a.
42. Bullock JD, Elder BL, Warwar RE, Snyder SA, Sizemore IE. 2014. Mechanism of drug failure in Fusarium keratitis, 2004-2006. N. Engl. J. Med. 370:88-89. http://dx.doi.org/10.1056/NEJMc1304053.
43. Chang DC, Grant GB, O’Donnell K, Wannemuehler KA, Noble-Wang J, Rao CY, Jacobson LM, Crowell CS, Sneed RS, Lewis FM, Schaffzin JK, Kainer MA, Genese CA, Alfonso EC, Jones DB, Srinivasan A, Fridkin SK, Park BJ, Fusarium Keratitis Investigation Team. 2006. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA 296:953-963. http://dx.doi.org/10.1001/jama.296.8.953.
44. Khor WB, Aung T, Saw SM, Wong TY, Tambyah PA, Tan AL, Beuerman R, Lim L, Chan WK, Heng WJ, Lim J, Loh RS, Lee SB, Tan DT. 2006. An outbreak of Fusarium keratitis associated with contact lens wear in Singapore. JAMA 295:2867-2873. http://dx.doi.org/10.1001/jama.295.24.2867.
45. Lutzoni F, Kauff F, Cox CJ, McLaughlin D, Celio G, Dentinger B, Padamsee M, Hibbett D, James TY, Baloch E, Grube M, Reeb V, Hofstetter V, Schoch C, Arnold AE, Miadlikowska J, Spatafora J, Johnson D, Hambleton S, Crockett M, Shoemaker R, Sung G-H, Lücking R, Lumbsch T, O’Donnell K, Binder M, Diederich P, Ertz D, Gueidan C, Hansen K, Harris RC, Hosaka K, Lim YW, Matheny B, Nishida H, Pfister D, Rogers J, Rossman A, Schmitt I, Sipman H, Stone J, Sugiyama J, Yahr R, Vilgalys R. 2004. Assembling the fungal tree of life: progress, classification, and evolution of subcellular traits. Am. J. Bot. 91:1446-1480. http://dx.doi.org/10.3732/ajb.91.10.1446.
46. Guindon S, Gascuel O. 2003. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst. Biol. 52: 696-704. http://dx.doi.org/10.1080/10635150390235520.
47. Gnerre S, MacCallum I, Przybylski D, Ribeiro FJ, Burton JN, Walker BJ, Sharpe T, Hall G, Shea TP, Sykes S, Berlin AM, Aird D, Costello M, Daza R, Williams L, Nicol R, Gnirke A, Nusbaum C, Lander ES, Jaffe DB. 2011. High-quality draft assemblies of mammalian genomes from massively parallel sequence data. Proc. Natl. Acad. Sci. U. S. A. 108: 1513-1518. http://dx.doi.org/10.1073/pnas.1017351108.
48. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA, Hanna M, McKenna A, Fennell TJ, Kernytsky AM, Sivachenko AY, Cibulskis K, Gabriel SB, Altshuler D, Daly MJ. 2011. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43:491-498. http://dx.doi.org/10.1038/ng.806.
49. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28:2731-2739. http://dx.doi.org/10.1093/molbev/msr121.
50. Lee SC, Li A, Calo S, Heitman J. 2013. Calcineurin plays key roles in the dimorphic transition and virulence of the human pathogenic zygomycete Mucor circinelloides. PLoS Pathog. 9:e1003625. http://dx.doi.org/10.1371/journal.ppat.1003625.
51. Mylonakis E, Moreno R, El Khoury JB, Idnurm A, Heitman J, Calderwood SB, Ausubel FM, Diener A. 2005. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect. Immun. 73:3842-3850. http://dx.doi.org/10.1128/IAI.73.7.3842-3850.2005.
52. Ibrahim AS, Avanessian V, Spellberg B, Edwards JE, Jr.. 2003. Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzae. Antimicrob. Agents Chemother. 47:3343-3344. http://dx.doi.org/10.1128/AAC.47.10.3343-3344.2003.
53. Waldorf AR, Ruderman N, Diamond RD. 1984. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J. Clin. Invest. 74:150-160. http://dx.doi.org/10.1172/JCI111395.